EEF2K and neurodegenerative disease: This leads to a pivotal role in drug development, and eEF2K is mainly being explored as a therapeutic target for numerous diseases, including cancers, neurodegenerative diseases, and cardiovascular diseases (Fujita et al., 2007; Beckelman et al., 2019; Temme and Asquith, 2021).